Back to Search
Start Over
Association of Anticholinergic Drug Burden with Cognitive and Functional Decline Over Time in Older Inpatients: Results from the CRIME Project
- Source :
- Drugsaging. 35(10)
- Publication Year :
- 2018
-
Abstract
- Medications with anticholinergic properties, although widely used, may negatively affect cognitive and functional status in older patients. To date there is still no standardized method to quantify anticholinergic exposure. We analyzed the relationship of two different tools for the evaluation of the anticholinergic drug burden with cognitive and functional impairment in a sample of older hospitalized patients. A retrospective and longitudinal analysis with 1-year follow-up of 1123 older hospitalized patients enrolled in seven Italian acute care wards was conducted. We assessed anticholinergic burden with the Anticholinergic Cognitive Burden (ACB) and Anticholinergic Risk Scale (ARS). Cognitive and functional status were evaluated at hospital discharge and during follow-up (3, 6, 12 months) using the Mini Mental State Examination (MMSE) and five basic activities of daily living (ADLs). Associations between anticholinergic burden and cognitive decline and incident disability were estimated using linear regression models for repeated measures and logistic models, respectively. The mean age of the study population was 81 ± 7.5 years. ACB and ARS classifications showed low correlation (Spearman’s rho = 0.39–0.43). Anticholinergic burden increased during hospitalization and was associated with cognitive and functional status. Patients with an ARS of ≥ 1 at discharge had significantly lower baseline MMSE scores (ARS = 0: 23.1; ARS ≥ 1: 20.8; p = 0.002) and during follow-up presented a significantly steeper MMSE score decline (− 0.15/month). Moreover, patients with an ACB of ≥ 1 at discharge had an almost threefold increased risk of developing disability (odds ratio 2.77, 95% confidence interval 1.39–5.54). ACB and ARS have only a moderate degree of correlation. Use of drugs with anticholinergic properties in elderly patients is independently associated with cognitive and functional decline.
- Subjects :
- Male
Aging
medicine.medical_specialty
Activities of daily living
medicine.drug_class
Socio-culturale
Cholinergic Antagonists
anticholinergic burden
03 medical and health sciences
0302 clinical medicine
Cognition
Internal medicine
Acute care
Activities of Daily Living
80 and over
medicine
Anticholinergic
Odds Ratio
Humans
Pharmacology (medical)
Cognitive Dysfunction
030212 general & internal medicine
Longitudinal Studies
Aged
Aged, 80 and over
Female
Hospitals
Inpatients
Italy
Retrospective Studies
Hospitalization
Cognitive decline
Mini–Mental State Examination
medicine.diagnostic_test
business.industry
Repeated measures design
Odds ratio
Confidence interval
Aging, epidemiology, anticholinergic burden, ADE
epidemiology
Geriatrics and Gerontology
business
ADE
030217 neurology & neurosurgery
Subjects
Details
- ISSN :
- 11791969
- Volume :
- 35
- Issue :
- 10
- Database :
- OpenAIRE
- Journal :
- Drugsaging
- Accession number :
- edsair.doi.dedup.....eda7738d8cfdeeef9236163cb518278b